Summit Overview
The European Risk Summit which was hosted by the Irish Medicines Board, King’s Centre for Risk Management and the Nickel Institute at Trinity College Dublin (11-12 June 2013), brought renewed focus to the issue of evidence and risk-based rulemaking, and highlighted the critical role that science plays in policy formation at EU level. The purpose of the Risk Summit was to discuss the advantages of […]
[ Read More]PANEL CHAIRS
Professor Ragnar Löfstedt
Mr Pat O’Mahony
Dr Kevin Bradley
Professor Ragnar Löfstedt,
Director,
King’s Centre for Risk Management
Ragnar E. Löfstedt is Professor of Risk Management and the Director of King’s Centre of Risk Management, King’s College London, UK where he teaches and conducts research on risk communication and management... [Read More]
Pat O’Mahony,
Chief Executive,
Irish Medicines Board
Having spent a number of years in private practice and as technical manager in the pharmaceutical industry in Ireland and the UK, Mr Pat O’Mahony, M.V.B., M.V.M., A.M.D., M.B.A., M.R.C.V.S. worked in public health... [Read more]
Dr Kevin Bradley,
President,
Nickel Institute
Dr Kevin Bradley is currently President of the Nickel Institute, the global representative body of the nickel metal and mining industry. The institute has 26 member companies including the top five multi-national mining conglomerates... [Read More]
Speaker Biographies
Dr. Reiner Wittkowski – Vice-President of the Federal Institute for Risk Assessment in Berlin
After completing his studies in the field of Food Chemistry at the Technical University of Berlin, in Germany, and obtaining a Doctorate Degree, he decided to carry out his post-doctoral research study at the University of California, Davis, USA. In 1986, he was also granted the “Deutsche Forschungsgemeinschaft” (German Society […]
